A carregar...
Zoledronic Acid Is Not Equally Potent on Osteoclasts Generated From Different Individuals
Zoledronic acid is a bisphosphonate commonly used to treat bone diseases such as osteoporosis and cancer‐induced bone disease. Patients exhibit a variable sensitivity to zoledronic acid; the underlying explanation for this remains unclear. The objective of this study was to obtain more knowledge in...
Na minha lista:
| Publicado no: | JBMR Plus |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7657394/ https://ncbi.nlm.nih.gov/pubmed/33210064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10412 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|